Some good news about the coronavirus thing.

 

Sign up for alerts

News Alert Sept. 23, 6:47 a.m. EDT Johnson & Johnson begins late-stage trials on a single-shot coronavirus vaccine The first coronavirus vaccine that aims to protect people with just a single shot has entered the final stages of testing in the United States, in an international trial that will recruit up to 60,000 participants. Paul Stoffels, chief scientific officer of J&J, said there may be enough data to have results by the end of the year on whether the vaccine is safe and effective, adding that the company plans to manufacture 1 billion doses next year. Read more

New York Times

BREAKING NEWS

Johnson & Johnson began the final stage of clinical trials for its coronavirus vaccine, which may only require one shot instead of two.

Wednesday, September 23, 2020 8:08 AM EST

This experimental vaccine may have considerable advantages over some of its competitors, experts said. It does not need to be stored in subzero temperatures, and may require just one dose instead of two.

Read the latest